The Gut Microbial Diversity of Newly Diagnosed Diabetics but Not of Prediabetics Is Significantly Different from That of Healthy Nondiabetics
Akshay H. Gaike, Dhiraj Paul, Shrikant S. Bhute, Dhiraj Dhotre, Pranav Pande, Smitha Upadhyaya, Yugandhar B. S. Reddy, Ramya Sampath, Debjani Ghosh, D. Chandraprabha, Jhankar Acharya, Gautam Banerjee, Vilas P. Sinkar, Saroj Ghaskadbi, Yogesh S. Shouche
Abstract
Gut microbiota is considered to play a role in disease progression, and previous studies have reported an association of microbiome dysbiosis with T2D. In this study, we have attempted to investigate gut microbiota of ND, PreDMs, NewDMs, and KnownDMs. We found that the genera Akkermansia and Blautia decreased significantly ( P < 0.05) in treatment-naive diabetics and were restored in KnownDMs on antidiabetic treatment. To the best of our knowledge, comparative studies on shifts in the microbial community in individuals of different diabetic states are lacking. Understanding the transition of microbiota and its association with serum biomarkers in diabetics with different disease states may pave the way for new therapeutic approaches for T2D.